13F HOLDINGS REPORT
Vivo Capital, LLC
Quarter ended Q1 2023 · Filed February 13, 2023 · Accession 0001213900-23-010818
Total Value
$868,543
Positions
48
Other Managers
0
Confidential Omitted
No
Holdings (48)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Harmony Biosciences Holdings Inc | HRMY | 2,606,247 | $143,604 | 16.53% |
| 2 | Terns Pharmaceuticals Inc | TERN | 6,657,992 | $67,778 | 7.80% |
| 3 | Viridian Therapeutics Inc | VRDN | 1,678,207 | $49,020 | 5.64% |
| 4 | ALX Oncology Holdings Inc | ALXO | 4,220,048 | $47,560 | 5.48% |
| 5 | Geron Corp | GERN | 19,282,834 | $46,664 | 5.37% |
| 6 | Impel NeuroPharma Inc | 45258K109 | 2,884,789 | $43,272 | 4.98% |
| 7 | Ventyx Biosciences Inc | 92332V107 | 1,303,294 | $42,735 | 4.92% |
| 8 | Sinovac Biotech Ltd. | SVA | 5,900,000 | $38,173 | 4.40% |
| 9 | Allakos Inc | 01671P100 | 4,120,134 | $34,692 | 3.99% |
| 10 | Tarsus Pharmaceuticals Inc | TARS | 2,262,200 | $33,164 | 3.82% |
| 11 | Vaxcyte Inc | PCVX | 579,508 | $27,787 | 3.20% |
| 12 | Astria Therapeutics Inc | 04635X102 | 1,681,199 | $25,033 | 2.88% |
| 13 | Cogent Biosciences Inc | COGT | 1,994,941 | $23,062 | 2.66% |
| 14 | Chinook Therapeutics Inc | 16961L106 | 872,151 | $22,850 | 2.63% |
| 15 | VectivBio Holding AG | H9060V101 | 2,333,300 | $20,218 | 2.33% |
| 16 | Avadel Pharmaceuticals PLC | 05337M104 | 2,754,095 | $19,719 | 2.27% |
| 17 | Compass Therapeutics Inc | CMPX | 3,557,630 | $17,895 | 2.06% |
| 18 | Aclaris Therapeutics, Inc. | ACRS | 898,631 | $14,153 | 1.63% |
| 19 | Legend Biotech Corp Sponsored | LEGN | 244,375 | $12,199 | 1.40% |
| 20 | Amyris, Inc | 03236M200 | 7,750,828 | $11,859 | 1.37% |
| 21 | Zai Lab Ltd ADR | ZLAB | 338,721 | $10,399 | 1.20% |
| 22 | Genetron Holdings Ltd | 37186H100 | 8,124,174 | $9,099 | 1.05% |
| 23 | Bellus Health Inc | 07987C204 | 1,017,152 | $8,361 | 0.96% |
| 24 | Instil Bio Inc | TIL | 12,486,787 | $7,867 | 0.91% |
| 25 | Vera Therapeutics Inc | VERA | 400,666 | $7,753 | 0.89% |
| 26 | IO Biotech Inc | IOBT | 3,015,545 | $6,936 | 0.80% |
| 27 | Merus NV | N5749R100 | 438,590 | $6,785 | 0.78% |
| 28 | Dyne Therapeutics Inc | DYN | 577,642 | $6,695 | 0.77% |
| 29 | Aadi Bioscience Inc | WHWK | 509,572 | $6,538 | 0.75% |
| 30 | KalVista Pharmaceuticals Inc. | KALV | 856,008 | $5,787 | 0.67% |
| 31 | Arrowhead Pharmaceuticals Inc | ARWR | 137,411 | $5,573 | 0.64% |
| 32 | BioAtla Inc | BCAB | 637,181 | $5,257 | 0.61% |
| 33 | Cincor Pharma Inc | 17240Y109 | 421,635 | $5,182 | 0.60% |
| 34 | Bolt Therapeutics Inc | BOLT | 3,871,291 | $5,033 | 0.58% |
| 35 | Iovance Biotherapeutics Inc | IOVA | 655,057 | $4,186 | 0.48% |
| 36 | DBV Technologies SA | DBVTF | 2,708,875 | $4,145 | 0.48% |
| 37 | Olema Pharmaceuticals Inc | OLMA | 1,689,515 | $4,139 | 0.48% |
| 38 | Verona Pharma PLC | 925050106 | 4,249,918 | $3,637 | 0.42% |
| 39 | Aligos Therapeutics Inc | ALGS | 3,547,030 | $3,380 | 0.39% |
| 40 | Sera Prognostics Inc | SERA | 1,856,011 | $2,339 | 0.27% |
| 41 | Gracell Biotechnologies Inc | 38406L103 | 961,358 | $2,211 | 0.25% |
| 42 | Codexis, Inc | CDXS | 388,144 | $1,809 | 0.21% |
| 43 | Aslan Pharmaceuticals Ltd | 04522R101 | 2,840,909 | $1,023 | 0.12% |
| 44 | Rezolute Inc | RZLT | 489,473 | $1,013 | 0.12% |
| 45 | Immunic Inc | IMUX | 632,184 | $833 | 0.10% |
| 46 | Minerva Surgical Inc | 60343F106 | 2,215,667 | $495 | 0.06% |
| 47 | Homology Medicines, Inc. | 438083107 | 370,068 | $466 | 0.05% |
| 48 | Precision Biosciences Inc | DTIL | 140,255 | $167 | 0.02% |